172 related articles for article (PubMed ID: 1512353)
1. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M
J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive evaluation of myocardial perfusion with use of technetium-99m teboroxime.
McGhie AI; Willerson JT
J Am Coll Cardiol; 1992 Sep; 20(3):720-1. PubMed ID: 1512354
[No Abstract] [Full Text] [Related]
3. Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium.
Melon PG; Beanlands RS; DeGrado TR; Nguyen N; Petry NA; Schwaiger M
J Am Coll Cardiol; 1992 Nov; 20(5):1277-83. PubMed ID: 1401632
[TBL] [Abstract][Full Text] [Related]
4. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow.
Glover DK; Ruiz M; Bergmann EE; Simanis JP; Smith WH; Watson DD; Beller GA
J Nucl Med; 1995 Mar; 36(3):476-83. PubMed ID: 7884514
[TBL] [Abstract][Full Text] [Related]
5. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability.
Abraham SA; Mirecki FN; Levine D; Nunn AD; Strauss HW; Gewirtz H
J Nucl Med; 1995 Jun; 36(6):1062-8. PubMed ID: 7769429
[TBL] [Abstract][Full Text] [Related]
6. Myocardial technetium 99m-labeled teboroxime clearance derived from canine scans differentiates severity of stenosis after dipyridamole.
Johnson G; Glover DK; Hebert CB; Okada RD
J Nucl Cardiol; 1994; 1(4):338-50. PubMed ID: 9420717
[TBL] [Abstract][Full Text] [Related]
7. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress.
Stewart RE; Heyl B; O'Rourke RA; Blumhardt R; Miller DD
J Nucl Med; 1991 Oct; 32(10):2000-8. PubMed ID: 1919745
[TBL] [Abstract][Full Text] [Related]
9. Experimental verification of technetium 99m-labeled teboroxime kinetic parameters in the myocardium with dynamic single-photon emission computed tomography: reproducibility, correlation to flow, and susceptibility to extravascular contamination.
Smith AM; Gullberg GT; Christian PE
J Nucl Cardiol; 1996; 3(2):130-42. PubMed ID: 8799238
[TBL] [Abstract][Full Text] [Related]
10. Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow.
Stewart RE; Schwaiger M; Hutchins GD; Chiao PC; Gallagher KP; Nguyen N; Petry NA; Rogers WL
J Nucl Med; 1990 Jul; 31(7):1183-90. PubMed ID: 2362197
[TBL] [Abstract][Full Text] [Related]
11. Myocardial accumulation and clearance of technetium 99m teboroxime at 100%, 75%, 50% and zero coronary blood flow in dogs.
Pieri P; Yasuda T; Fischman AJ; Ahmad M; Moore R; Yaoita H; Strauss HW
Eur J Nucl Med; 1991; 18(9):725-31. PubMed ID: 1936048
[TBL] [Abstract][Full Text] [Related]
12. Tomographic myocardial perfusion imaging with technetium-99m-teboroxime at rest and after dipyridamole.
Li QS; Solot G; Frank TL; Wagner HN; Becker LC
J Nucl Med; 1991 Oct; 32(10):1968-76. PubMed ID: 1919740
[TBL] [Abstract][Full Text] [Related]
13. Early myocardial clearance kinetics of technetium-99m-teboroxime differentiate normal and flow-restricted canine myocardium at rest.
Johnson G; Glover DK; Hebert CB; Okada RD
J Nucl Med; 1993 Apr; 34(4):630-6. PubMed ID: 8455080
[TBL] [Abstract][Full Text] [Related]
14. Myocardial clearance kinetics of technetium-99m-teboroxime following dipyridamole: differentiation of stenosis severity in canine myocardium.
Johnson G; Glover DK; Hebert CB; Okada RD
J Nucl Med; 1995 Jan; 36(1):111-9. PubMed ID: 7799062
[TBL] [Abstract][Full Text] [Related]
15. Myocardial kinetics of TcN-NOET: a neutral lipophilic complex tracer of regional myocardial blood flow.
Ghezzi C; Fagret D; Arvieux CC; Mathieu JP; Bontron R; Pasqualini R; de Leiris J; Comet M
J Nucl Med; 1995 Jun; 36(6):1069-77. PubMed ID: 7769430
[TBL] [Abstract][Full Text] [Related]
16. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
Beller GA; Watson DD
Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
[TBL] [Abstract][Full Text] [Related]
17. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart.
Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
J Nucl Med; 1991 Oct; 32(10):1979-88. PubMed ID: 1919742
[TBL] [Abstract][Full Text] [Related]
18. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
Meerdink DJ; Leppo JA
Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis.
Gray WA; Gewirtz H
Circulation; 1991 Oct; 84(4):1796-807. PubMed ID: 1914115
[TBL] [Abstract][Full Text] [Related]
20. Physiologic properties of myocardial perfusion tracers.
Dahlberg ST; Leppo JA
Cardiol Clin; 1994 May; 12(2):169-85. PubMed ID: 8033171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
